Liposomes and niosomes as potential carriers for dermal delivery of minoxidil

被引:79
作者
Mura, Simona
Pirot, Fabrice
Manconi, Maria
Falson, Francoise
Fadda, Anna M.
机构
[1] Univ Cagliari, Dipartimento Farmaco Chim Technol, I-09124 Cagliari, Italy
[2] Univ Lyon 1, Inst Sci Pharmaceut & Biol, Lab Rech & Dev Pharm Galen Ind, EA 3741, F-69373 Lyon 08, France
关键词
vesicle systems; soy phosphatidylcholine; lecithin; alkylpolyglucoside surfactants; skin drug delivery; hair follicles;
D O I
10.1080/10611860600991993
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to formulate minoxidil loaded liposome and niosome formulations to improve skin drug delivery. Multilamellar liposomes were prepared using soy phosphatidylcholine at different purity degrees (Phospholipon (R) 90, 90% purity, soy lecithin (SL), 75% purity) and cholesterol (Chol), whereas niosomes were made with two different commercial mixtures of alkylpolyglucoside (APG) surfactants (Oramix (R) NS10, Oramix (R) CG 110), Chol and dicetylphosphate. Minoxidil skin penetration and permeation experiments were performed in vitro using vertical diffusion Franz cells and human skin treated with either drug vesicular systems or propylene glycol-water-ethanol solution (control). Penetration of minoxidil in epidermal and dermal layers was greater with liposomes than with niosomal formulations and the control solution. These differences might be attributed to the smaller size and the greater potential targeting to skin and skin appendages of liposomal carriers, which enhanced globally the skin drug delivery. The greatest skin accumulation was always obtained with nondialysed vesicular formulations. No permeation of minoxidil through the whole skin thickness was detected in the present study irrespective of the existence of hair follicles. Alcohol-free liposomal formulations would constitute a promising approach for the topical delivery of minoxidil in hair loss treatment.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 41 条
[1]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[2]  
Brzezinska-Wcislo Ligia, 2002, Pol Merkur Lekarski, V13, P208
[3]  
Budai M, 2001, Acta Pharm Hung, V71, P114
[4]   Lipid vesicles and other colloids as drug carriers on the skin [J].
Cevc, G .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :675-711
[5]   Follicular liposomal delivery systems [J].
Ciotti, SN ;
Weiner, N .
JOURNAL OF LIPOSOME RESEARCH, 2002, 12 (1-2) :143-148
[6]  
DARGIE HJ, 1977, LANCET, V2, P515
[7]  
Davis AF, 2002, DRUGS PHARM SCI, V119, P271
[8]   THE INFLUENCE OF PARTICLE-SIZE OF LIPOSOMES ON THE DEPOSITION OF DRUG INTO SKIN [J].
DUPLESSIS, J ;
RAMACHANDRAN, C ;
WEINER, N ;
MULLER, DG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 103 (03) :277-282
[9]   USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN [J].
JACOBS, JP ;
SZPUNAR, CA ;
WARNER, ML .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (10) :758-762
[10]   DEHYDRATION-REHYDRATION VESICLES - A SIMPLE METHOD FOR HIGH-YIELD DRUG ENTRAPMENT IN LIPOSOMES [J].
KIRBY, C ;
GREGORIADIS, G .
BIO-TECHNOLOGY, 1984, 2 (11) :979-984